Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Notice for belzutifan (Merck Sharp & Dohme (Australia) Pty Ltd)
Active ingredients
belzutifan
Date of review outcome
Lapse date
Type
Provisional determination
Dosage form(s)
Immediate-release tablet
Therapeutic area
Oncology